Skip to main content

Table 2 Association of persistence with antiplatelets on long-term mortalitya after ischemic stroke

From: Effect of antiplatelet persistence on long-term mortality and predictors of non-persistence in ischemic stroke patients 75 years and older: a nationwide cohort study

Duration of antiplatelets All-cause mortality CVD mortality Non-CVD mortality
Event No Crude
HR
(95% CI)
p value Adjusted HRb
(95% CI)
p value Event No Crude
HR
(95% CI)
p value Adjusted HRb
(95% CI)
p value Event No Crude
HR
(95% CI)
p value Adjusted HRb
(95% CI)
p value
Non-persistent
(< 6 months)
(n = 321)
173 2.35
(1.90-2.91)
0.000 2.13
(1.72-2.65)
0.000 63 2.40
(1.68-3.42)
0.000 2.26
(1.57-3.24)
0.000 110 2.33
(1.78-3.03)
0.000 2.06
(1.57-2.70)
0.000
Persistent
(≥ 6 months)
(n = 556)
168 Reference Reference 59 Reference Reference 109 Reference Reference
  1. Analysis was performed using Cox proportional hazard regression model
  2. Abbreviations: CVD Cerebro-cardiovascular disease, No Number, HR Hazard ratio
  3. aMedian follow-up was 3.17 years
  4. bAdjusted for sex, age, income, residential area, type of insurance, Charlson comorbidity index, and number of prescribed medications